Patient Care Insights

Analyzing treatment at the point of care

How you approach market opportunities is directly linked to how you understand physician behaviors and patient care. As a longtime partner to providers and a leading patient care advocate, we can help you focus your market strategy using a more holistic view of a patient's treatment journey.


Predicting oncology utilization patterns  

PrecisionIQ helps you forecast the adoption of new products and evaluate market dynamics for business development opportunities. Our projection methodology uses real-world longitudinal oncology treatment data across over 80 malignancies to account for physician behavior—such as under-dosing, toxicity management and drug cycle utilization.

We apply parameters such as age, gender, disease stage, biomarkers and line of therapy to uncover insights into the current patterns of national drug usage. Using more refined population segmentation and statistical estimation, we can project adoption and utilization within an individual condition across and within subpopulations.

Our predictive modeling is rooted in data from more than:
cancer treatments
cancer patients
administrations of drug therapy


Insight into patterns of care

Our IntelliVIEW solution offers a real-time snapshot of clinical usage patterns and trends at the drug, regimen or patient level. It provides you with nationally projected drug utilization for both IV and oral oncolytics, as well as a longitudinal track of all lines of therapy from over 69,000 unique cancer patients per year.

Broken out across four regions of the United States, you can gain powerful insights from metrics segmented by specific drug and regimen, patient characteristics and unique patient condition. With such a robust data set at your disposal, you can more effectively understand your market share and analyze patient populations to evaluate patterns in dosing.

Your insights are waiting.

When it comes to data, bigger really is better. Discover the insights you can unlock when you tap into the power of the AmerisourceBergen network.
Start the conversation